Surgery, Gastroenterology and Oncology
Vol. 23, No. 5, Oct 2018
Risk Factors for Recurrence of Hepatocellular Carcinoma after Curative Resection
Mitsugi Shimoda, Tsunehiko Maruyama, Kazuomi Suzuki, Tomoya Tago, Kiyotaka Nishida, Jiro Shimazaki, Shuji Suzuki
ORIGINAL PAPER, Oct 2018
Article DOI: 10.21614/sgo-23-5-314
Background Aims: Hepatic surgical resection is one of the most effective treatment for hepatocellular carcinoma (HCC). However, recurrence of HCC (HCCR) is still very common among operated patients, and its risk factors still remains unclear.

Materials and Methods: We have conducted a retrospective study of 56 patients operated for HCC in our medical center during April 2008 through March 2016, to analyze the risk factors for HCCR. The ideal cutoff values of laboratory parameters was defined using the Receiver Operating Characteristic (ROC) curve analysis, and logistic regression model analyses were used to calculate odds ratios with 95% CI. P values less than 0.05 were considered as statistically significant.

Results and Conclusion: All 56 patients accrued to this retrospective study underwent curative resection of HCC. The patients compromised of 11 female and 45 male, with the median age of 68.5years.
Twenty-three out of 56 (40.1%) patients experienced HCC recurrence, and the Median time of recurrence was 14.5 months.The 5-year cancer-free survival rate was 42.5%.
Univariate analysis showed that the use of intermittent Pringle Maneuver (IPM: p=0.036), limited resection (LR: p=0.011), and cancerous infiltration of the capsule (fc-inf; p=0.017), were associated with HCC recurrence. According to the multivariate analysis, using IPM (p=0.008), LR (p=0.012), and fc-inf (p=0.014), were risk factors for patients with HCCR.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 3679


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.